Lead, zinc and copper decorporation during calcium disodium ethylenediamine tetraacetate treatment of lead-poisoned children
Thomas DJ, Chisolm J Jr. Lead, zinc and copper decorporation during calcium disodium ethylenediamine tetraacetate treatment of lead-poisoned children. J Pharmacol Exp Ther. 1986;239:829-835
Centers for Disease Control and Prevention, Atlanta, GA: Centers for Disease Control and Prevention;, Available at:, Accessed April 6
Centers for Disease Control and Prevention. Preventing Lead Poisoning in Young Children: A Statement by the Centers for Disease Control. Atlanta, GA: Centers for Disease Control and Prevention; 1985. Available at: www.cdc.gov/nceh/lead/Publications/books/plpyc/plpyc_history/CLP_198. Accessed April 6, 2006
meso-2,3-Dimercaptosuccinic acid: Chemical, pharmacological and toxicological properties of an orally effective metal chelating agent
Aposhian HV, Aposhian MM. meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent. Annu Rev Pharmacol Toxicol. 1990;30:279-306
Agency for Toxic Substances and Disease Registry, Atlanta, GA: US Department Health and Human Services, Agency for Toxic Substances and Disease Registry;
Agency for Toxic Substances and Disease Registry. Toxicological Profile for Lead. Atlanta, GA: US Department Health and Human Services, Agency for Toxic Substances and Disease Registry; 1999
Endrate [package insert, Lake Forest, IL: Hospira Inc; 2005
Endrate [package insert]. Lake Forest, IL: Hospira Inc; 2005
14
0003505586
Centers for Disease Control and Prevention, Atlanta, GA: Centers for Disease Control and Prevention;, Available at:, Accessed April 6
Centers for Disease Control and Prevention. Preventing Lead Poisoning in Young Children: A Statement by the Centers for Disease Control. Atlanta, GA: Centers for Disease Control and Prevention; 1978. Available at: www.cdc.gov/nceh/lead/Publications/books/plpyc/plpyc_history/CLP_197. Accessed April 6, 2006
National Center for Complementary and Alternative Medicine, National Institutes of Health. NIH launches large clinical trial on EDTA chelation therapy for coronary artery disease [press release]. Bethesda, MD: National Institutes for Health; August 7, 2002. Available at: http://nccam.nih.gov/news/ 2002/chelation/pressrelease.htm. Accessed March 3, 2006
National Center for Complementary and Alternative Medicine, National Institutes of Health. NIH launches large clinical trial on EDTA chelation therapy for coronary artery disease [press release]. Bethesda, MD: National Institutes for Health; August 7, 2002. Available at: http://nccam.nih.gov/news/ 2002/chelation/pressrelease.htm. Accessed March 3, 2006
* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.